Clinical Trials Logo

Infiltrative Bladder Carcinoma clinical trials

View clinical trials related to Infiltrative Bladder Carcinoma.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT01245660 Terminated - Bladder Carcinoma Clinical Trials

A Phase 0 of Neoadjuvant Lapatinib in Infiltrative Bladder Carcinoma Before Cystectomy

LAPAINBLAD
Start date: January 2011
Phase: Phase 0
Study type: Interventional

Modification of the EGF signalling pathway and / or HER 2, by Lapatinib in bladder cancer.